Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valerio Nobili

Showing results (41-50 of 338) with videos related to

Pageof 34
Sort By:
Hepatology (Baltimore, Md.)|November 26, 2009
Diagnostic power of fibroscan in predicting liver fibrosis in nonalcoholic fatty liver diseaseAnna Alisi, Massimo Pinzani, Valerio Nobili
Hepatology (Baltimore, Md.)|September 27, 2012
I148M PNPLA3 variant and progressive liver disease: a new paradigm in hepatologyLuca Valenti, Anna Alisi, Valerio Nobili
Pediatric Transplantation|January 24, 2007
Food allergy in pediatric liver transplant recipients: harmful or harmless?Roberto Guidi, Valerio Nobili, Matilde Marcellini
BMJ (Clinical Research Ed.)|February 18, 2006
Clinical course of infection with hepatitis CSandro Vento, Valerio Nobili, Francesca Cainelli
Hepatology (Baltimore, Md.)|April 8, 2010
The link between hepatosteatosis and cells of the immune systemAnna Alisi, Nadia Panera, Valerio Nobili
Hepatology (Baltimore, Md.)|November 5, 2008
Risk of severe liver disease in NAFLD with normal ALT levels: a pediatric reportMelania Manco, Anna Alisi, Valerio Nobili
Hepatology (Baltimore, Md.)|November 3, 2011
Pathogen- or damage-associated molecular patterns during nonalcoholic fatty liver disease developmentAnna Alisi, Rita Carsetti, Valerio Nobili
Hepatology (Baltimore, Md.)|February 7, 2012
I148M PNPLA3 variant and progressive liver disease: A new paradigm in hepatologyLuca Valenti, Anna Alisi, Valerio Nobili
World Journal of Gastroenterology|August 2, 2014
Epidemiology of fatty liver: an updateGiorgio Bedogni, Valerio Nobili, Claudio Tiribelli
Biomarkers in Medicine|December 12, 2012
Circulating biomarkers for metabolic disorders as a predictor of cardiovascular disease risk: what's new?Valerio Nobili, Valentina Giorgio, Giacomo Pongiglione
Pageof 34

Showing results (41-50 of 338) with videos related to

Sort By:
Pageof 34
Hepatology (Baltimore, Md.)|November 26, 2009
Diagnostic power of fibroscan in predicting liver fibrosis in nonalcoholic fatty liver diseaseAnna Alisi, Massimo Pinzani, Valerio Nobili
Hepatology (Baltimore, Md.)|September 27, 2012
I148M PNPLA3 variant and progressive liver disease: a new paradigm in hepatologyLuca Valenti, Anna Alisi, Valerio Nobili
Pediatric Transplantation|January 24, 2007
Food allergy in pediatric liver transplant recipients: harmful or harmless?Roberto Guidi, Valerio Nobili, Matilde Marcellini
BMJ (Clinical Research Ed.)|February 18, 2006
Clinical course of infection with hepatitis CSandro Vento, Valerio Nobili, Francesca Cainelli
Hepatology (Baltimore, Md.)|April 8, 2010
The link between hepatosteatosis and cells of the immune systemAnna Alisi, Nadia Panera, Valerio Nobili
Hepatology (Baltimore, Md.)|November 5, 2008
Risk of severe liver disease in NAFLD with normal ALT levels: a pediatric reportMelania Manco, Anna Alisi, Valerio Nobili
Hepatology (Baltimore, Md.)|November 3, 2011
Pathogen- or damage-associated molecular patterns during nonalcoholic fatty liver disease developmentAnna Alisi, Rita Carsetti, Valerio Nobili
Hepatology (Baltimore, Md.)|February 7, 2012
I148M PNPLA3 variant and progressive liver disease: A new paradigm in hepatologyLuca Valenti, Anna Alisi, Valerio Nobili
World Journal of Gastroenterology|August 2, 2014
Epidemiology of fatty liver: an updateGiorgio Bedogni, Valerio Nobili, Claudio Tiribelli
Biomarkers in Medicine|December 12, 2012
Circulating biomarkers for metabolic disorders as a predictor of cardiovascular disease risk: what's new?Valerio Nobili, Valentina Giorgio, Giacomo Pongiglione
Pageof 34